ArticleDiscover oncology2025
Single cell analysis and bioinformatics reveal pyroptosis mechanisms in hepatocellular carcinoma.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Involvement of the pyroptosis-HMGB1 axis in systemic diseases.Frontiers in cell and developmental biology · 2026Review
- Geranylgeranoic acid, toll-like receptor 4, and pyroptosis-related signaling in hepatocellular carcinoma: a hypothesis-generating perspective.Oncology reviews · 2026Article
- MED8 is related to tumor immunity and has predictive value in the prognosis and treatment of glioma.Discover oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHepatocellular carcinoma (HCC) is the third leading cause of cancer related death, and its molecular mechanisms have not been fully elucidated. This study aims to elucidate the molecular mechanisms linking pyroptosis and immune microenvironment changes in HCC, with a focus on macrophage polarization and inflammatory responses.
methodsSelected gene expression profiles from the Gene Expression Omnibus database, established protein-protein interaction (PPI) networks, and performed functional enrichment analysis using databases such as the Kyoto Encyclopedia of Genes and Genomes (KEGG). The expression of relevant hub genes was verified by immunohistochemistry, real-time quantitative PCR, and Western Blot based on clinical tissues. Single-cell identification of HCC cell types and malignant cells, trajectory analysis, and intercellular signal communication further analyzed the molecular mechanisms between immune cells and liver cells. Bioinformatics combined with single-cell analysis to elucidate the immune pyroptosis molecular mechanism that underlay the development of HCC.
resultsMolecular biology has identified six pyroptosis hub genes in HCC. The key hub genes of immune pyroptosis were validated through immunohistochemistry and in vitro experiments. Enrichment analysis shows that intersecting genes are enriched in immune responses, chemokine mediated signaling pathways, and inflammatory responses. InferCNV and copyKAT accurately predict that malignant cells distribute in HCC tissues, and their main malignant cells may be hepatocytes, endothelium and epithelial cells. Cell trajectory analysis found that monocyte, macrophage polarization could play a first role in HCC. The cellular clustering of single cells revealed the infiltration of immune cells, especially the polarization of macrophages, which plays an important role. Immunohistochemistry suggests that hub genes such as HMGB1, CYCS, GSDMD, IL-1β, NLRP3, and IL18 are the link between macrophage polarization and pyroptosis during HCC development.
conclusionsIn summary, the main molecular mechanisms underlying the pathogenesis of HCC are related to immune cell infiltration, particularly macrophage infiltration polarization that promotes the secretion of inflammatory factors leading to hepatocyte pyroptosis. These findings provide novel insights into the macrophage-driven pyroptosis pathways in HCC, potentially paving the way for new immunotherapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.